PubMed ID: 35869049
Author(s): Marola OJ, Yablonski SER, Shrager PG, Nickells RW, Libby RT. BclX(L) (Bcl2l1) gene therapy lessens retinal ganglion cell soma loss but not axonal degeneration after acute axonal injury. Cell Death Discov. 2022 Jul 22;8(1):331. doi: 10.1038/s41420-022-01111-4. PMID 35869049
Journal: Cell Death Discovery, Volume 8, Issue 1, Jul 2022